{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T12:23:20Z","timestamp":1784809400530,"version":"3.55.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81973616"],"award-info":[{"award-number":["81973616"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Project of International Cooperation and Exchanges of the National Natural Science Foundation of China","award":["No. 82020108017"],"award-info":[{"award-number":["No. 82020108017"]}]},{"name":"Innovation Group Project of National Natural Science Foundation of China","award":["No.81921002"],"award-info":[{"award-number":["No.81921002"]}]},{"name":"National Key Research and Development Program of China","award":["No. 2017FYA0205301"],"award-info":[{"award-number":["No. 2017FYA0205301"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-25973-7","type":"journal-article","created":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T12:51:34Z","timestamp":1764161494000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The mechanism of luteolin suppressing pancreatic cancer (PC) via cyclin B1\u00a0(CCNB1)-mediated signalling"],"prefix":"10.1038","volume":"15","author":[{"given":"Linjia","family":"Peng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaonan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinxin","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiting","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanfeng","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuli","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiguang","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-1206-0747","authenticated-orcid":false,"given":"Daxiang","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,26]]},"reference":[{"issue":"5","key":"25973_CR1","doi-asserted-by":"publisher","first-page":"375","DOI":"10.3322\/caac.21626","volume":"70","author":"AJ Grossberg","year":"2020","unstructured":"Grossberg, A. J. et al. Multidisciplinary standards of care and recent progress in pancreatic ductal adenocarcinoma [J]. Cancer J. Clin. 70 (5), 375\u2013403 (2020).","journal-title":"Cancer J. Clin."},{"issue":"3","key":"25973_CR2","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J]. CA Cancer J. Clin. 71 (3), 209\u2013249 (2021).","journal-title":"CA Cancer J. Clin."},{"issue":"10242","key":"25973_CR3","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1016\/S0140-6736(20)30974-0","volume":"395","author":"JD Mizrahi","year":"2020","unstructured":"Mizrahi, J. D. et al. Pancreatic cancer [J]. Lancet (London England). 395 (10242), 2008\u20132020 (2020).","journal-title":"Lancet (London England)"},{"key":"25973_CR4","unstructured":"Canto, W. O. O. D. L. D. et al. E M,. Pancreatic Cancer: Pathogenesis, Screening, Diagnosis and Treatment [J]. Gastroenterology, (2022)."},{"issue":"3","key":"25973_CR5","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1021\/acs.jnatprod.5b01055","volume":"79","author":"DJ Newman","year":"2016","unstructured":"Newman, D. J. & Cragg, G. M. Natural products as sources of new drugs from 1981 to 2014 [J]. J. Nat. Prod. 79 (3), 629\u2013661 (2016).","journal-title":"J. Nat. Prod."},{"key":"25973_CR6","doi-asserted-by":"crossref","unstructured":"Arena, A. C. et al. Natural Products as Sources of New Analgesic Drugs [J]. Evidence-based complementary and alternative medicine: eCAM, 2022: 9767292. (2022).","DOI":"10.1155\/2022\/9767292"},{"issue":"2","key":"25973_CR7","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1111\/1750-3841.14994","volume":"85","author":"SM Ahmadi","year":"2020","unstructured":"Ahmadi, S. M. et al. Structure-Antioxidant activity relationships of Luteolin and Catechin [J]. J. Food Sci. 85 (2), 298\u2013305 (2020).","journal-title":"J. Food Sci."},{"key":"25973_CR8","doi-asserted-by":"publisher","unstructured":"Singh Tuli, H. et al. Luteolin, a potent anticancer compound: from chemistry to cellular interactions and synergetic perspectives [J]. Cancers, 14(21). https:\/\/doi.org\/10.3390\/cancers14215373  (2022).","DOI":"10.3390\/cancers14215373"},{"issue":"3","key":"25973_CR9","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.3892\/ijo.2015.2831","volume":"46","author":"HJ Cho","year":"2015","unstructured":"Cho, H. J. et al. Luteolin acts as a radiosensitizer in non\u2013small cell lung cancer cells by enhancing apoptotic cell death through activation of a p38\/ROS\/caspase cascade [J]. Int. J. Oncol. 46 (3), 1149\u20131158 (2015).","journal-title":"Int. J. Oncol."},{"key":"25973_CR10","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.lfs.2018.08.025","volume":"209","author":"E Im","year":"2018","unstructured":"Im, E., Yeo, C. & Lee, E. O. Luteolin induces caspase-dependent apoptosis via inhibiting the AKT\/osteopontin pathway in human hepatocellular carcinoma SK-Hep-1 cells [J]. Life Sci. 209, 259\u2013266 (2018).","journal-title":"Life Sci."},{"issue":"4","key":"25973_CR11","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1002\/med.21880","volume":"42","author":"AM Juszczak","year":"2022","unstructured":"Juszczak, A. M. et al. Skin cancer, including related pathways and therapy and the role of Luteolin derivatives as potential therapeutics [J]. Med. Res. Rev. 42 (4), 1423\u20131462 (2022).","journal-title":"Med. Res. Rev."},{"key":"25973_CR12","doi-asserted-by":"publisher","unstructured":"Chen, Y. H. et al. Synergistic combination of Luteolin and Asiatic acid on cervical cancer in vitro and in vivo [J]. Cancers, 15(2). https:\/\/doi.org\/10.3390\/cancers15020548 (2023).","DOI":"10.3390\/cancers15020548"},{"issue":"10","key":"25973_CR13","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.7150\/ijms.73947","volume":"19","author":"HW Lin","year":"2022","unstructured":"Lin, H. W. et al. Luteolin reduces aqueous extract PM2.5-induced metastatic activity in H460 lung cancer cells [J]. Int. J. Med. Sci. 19 (10), 1502\u20131509 (2022).","journal-title":"Int. J. Med. Sci."},{"issue":"1","key":"25973_CR14","doi-asserted-by":"publisher","first-page":"26239","DOI":"10.1038\/s41598-024-77032-2","volume":"14","author":"XZ Li","year":"2024","unstructured":"Li, X. Z. et al. Flavopiridol induces cell cycle arrest and apoptosis by interfering with CDK1 signaling pathway in human ovarian granulosa cells [J]. Sci. Rep. 14 (1), 26239 (2024).","journal-title":"Sci. Rep."},{"key":"25973_CR15","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1758-2946-6-13","volume":"6","author":"J Ru","year":"2014","unstructured":"Ru, J. et al. TCMSP: a database of systems Pharmacology for drug discovery from herbal medicines [J]. J. Cheminform. 6, 13 (2014).","journal-title":"J. Cheminform"},{"issue":"W1","key":"25973_CR16","doi-asserted-by":"publisher","first-page":"W357","DOI":"10.1093\/nar\/gkz382","volume":"47","author":"A Daina","year":"2019","unstructured":"Daina, A., Michielin, O. & Zoete, V. SwissTargetPrediction: updated data and new features for efficient prediction of protein targets of small molecules [J]. Nucleic Acids Res. 47 (W1), W357\u2013w64 (2019).","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"25973_CR17","doi-asserted-by":"publisher","first-page":"15175","DOI":"10.1038\/s41598-024-64981-x","volume":"14","author":"S Yang","year":"2024","unstructured":"Yang, S. et al. Disulfiram downregulates ferredoxin 1 to maintain copper homeostasis and inhibit inflammation in cerebral ischemia\/reperfusion injury [J]. Sci. Rep. 14 (1), 15175 (2024).","journal-title":"Sci. Rep."},{"issue":"1","key":"25973_CR18","first-page":"17","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel, R. L. et al. Cancer statistics, 2023 [J]. CA Cancer J. Clin. 73 (1), 17\u201348 (2023).","journal-title":"CA Cancer J. Clin."},{"issue":"7","key":"25973_CR19","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1053\/j.gastro.2019.01.259","volume":"156","author":"AD Singhi","year":"2019","unstructured":"Singhi, A. D. et al. Early detection of pancreatic cancer: opportunities and challenges [J]. Gastroenterology 156 (7), 2024\u20132040 (2019).","journal-title":"Gastroenterology"},{"key":"25973_CR20","doi-asserted-by":"publisher","first-page":"102180","DOI":"10.1016\/j.ctrv.2021.102180","volume":"96","author":"S De Dosso","year":"2021","unstructured":"De Dosso, S. et al. Treatment landscape of metastatic pancreatic cancer [J]. Cancer Treat. Rev. 96, 102180 (2021).","journal-title":"Cancer Treat. Rev."},{"issue":"6","key":"25973_CR21","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/s41575-018-0005-x","volume":"15","author":"JP Neoptolemos","year":"2018","unstructured":"Neoptolemos, J. P. et al. Therapeutic developments in pancreatic cancer: current and future perspectives [J]. Nat. Rev. Gastroenterol. Hepatol. 15 (6), 333\u2013348 (2018).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"16","key":"25973_CR22","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1200\/JCO.2014.59.7625","volume":"33","author":"AH Ko","year":"2015","unstructured":"Ko, A. H. Progress in the treatment of metastatic pancreatic cancer and the search for next opportunities [J]. J. Clin. Oncology: Official J. Am. Soc. Clin. Oncol. 33 (16), 1779\u20131786 (2015).","journal-title":"J. Clin. Oncology: Official J. Am. Soc. Clin. Oncol."},{"issue":"5","key":"25973_CR23","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1007\/s00280-017-3299-4","volume":"79","author":"Q Wang","year":"2017","unstructured":"Wang, Q. et al. Luteolin induces apoptosis by ROS\/ER stress and mitochondrial dysfunction in gliomablastoma [J]. Cancer Chemother. Pharmacol. 79 (5), 1031\u20131041 (2017).","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"1","key":"25973_CR24","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s12967-017-1151-6","volume":"15","author":"MD Zang","year":"2017","unstructured":"Zang, M. D. et al. Luteolin suppresses gastric cancer progression by reversing epithelial-mesenchymal transition via suppression of the Notch signaling pathway [J]. J. Transl Med. 15 (1), 52 (2017).","journal-title":"J. Transl Med."},{"issue":"1","key":"25973_CR25","doi-asserted-by":"publisher","first-page":"11255","DOI":"10.1038\/s41598-018-29308-7","volume":"8","author":"HW Zhang","year":"2018","unstructured":"Zhang, H. W. et al. Flavonoids inhibit cell proliferation and induce apoptosis and autophagy through downregulation of PI3K\u03b3 mediated PI3K\/AKT\/mTOR\/p70S6K\/ULK signaling pathway in human breast cancer cells [J]. Sci. Rep. 8 (1), 11255 (2018).","journal-title":"Sci. Rep."},{"key":"25973_CR26","doi-asserted-by":"publisher","first-page":"114350","DOI":"10.1016\/j.biopha.2023.114350","volume":"160","author":"Y Li","year":"2023","unstructured":"Li, Y. et al. Luteolin directly binds to KDM4C and attenuates ovarian cancer stemness via epigenetic suppression of PPP2CA\/YAP axis [J]. Biomed. Pharmacother. 160, 114350 (2023).","journal-title":"Biomed. Pharmacother"},{"issue":"4","key":"25973_CR27","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.3892\/or.2012.1914","volume":"28","author":"X Cai","year":"2012","unstructured":"Cai, X. et al. The molecular mechanism of luteolin-induced apoptosis is potentially related to Inhibition of angiogenesis in human pancreatic carcinoma cells [J]. Oncol. Rep. 28 (4), 1353\u20131361 (2012).","journal-title":"Oncol. Rep."},{"issue":"7","key":"25973_CR28","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1093\/carcin\/bgab017","volume":"42","author":"H Kato","year":"2021","unstructured":"Kato, H. et al. DPYD, down-regulated by the potentially chemopreventive agent luteolin, interacts with STAT3 in pancreatic cancer [J]. Carcinogenesis 42 (7), 940\u2013950 (2021).","journal-title":"Carcinogenesis"},{"key":"25973_CR29","doi-asserted-by":"publisher","first-page":"2989","DOI":"10.2147\/OTT.S91511","volume":"8","author":"X Huang","year":"2015","unstructured":"Huang, X. et al. Luteolin decreases invasiveness, deactivates STAT3 signaling, and reverses interleukin-6 induced epithelial-mesenchymal transition and matrix metalloproteinase secretion of pancreatic cancer cells [J]. Onco Targets Ther. 8, 2989\u20133001 (2015).","journal-title":"Onco Targets Ther."},{"issue":"5","key":"25973_CR30","doi-asserted-by":"publisher","first-page":"3018","DOI":"10.1039\/C8FO00033F","volume":"9","author":"Z Li","year":"2018","unstructured":"Li, Z. et al. The dietary compound Luteolin inhibits pancreatic cancer growth by targeting BCL-2 [J]. Food Funct. 9 (5), 3018\u20133027 (2018).","journal-title":"Food Funct."},{"issue":"1","key":"25973_CR31","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41580-021-00404-3","volume":"23","author":"HK Matthews","year":"2022","unstructured":"Matthews, H. K., Bertoli, C. & DE Bruin R A M. Cell cycle control in cancer [J]. Nat. Rev. Mol. Cell. Biol. 23 (1), 74\u201388 (2022).","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"issue":"12","key":"25973_CR32","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1016\/j.tibs.2022.06.007","volume":"47","author":"M Fischer","year":"2022","unstructured":"Fischer, M. et al. Coordinating gene expression during the cell cycle [J]. Trends Biochem. Sci. 47 (12), 1009\u20131022 (2022).","journal-title":"Trends Biochem. Sci."},{"key":"25973_CR33","doi-asserted-by":"publisher","first-page":"116798","DOI":"10.1016\/j.ecoenv.2024.116798","volume":"283","author":"ZN Pan","year":"2024","unstructured":"Pan, Z. N. et al. Propylparaben exposure impairs G2\/M and metaphase-anaphase transition during mouse oocyte maturation [J]. Ecotoxicol. Environ. Saf. 283, 116798 (2024).","journal-title":"Ecotoxicol. Environ. Saf."},{"issue":"2","key":"25973_CR34","doi-asserted-by":"publisher","first-page":"e2214829120","DOI":"10.1073\/pnas.2214829120","volume":"120","author":"M Qu","year":"2023","unstructured":"Qu, M. et al. Circadian regulator BMAL1::CLOCK promotes cell proliferation in hepatocellular carcinoma by controlling apoptosis and cell cycle [J]. Proc. Natl. Acad. Sci. U S A. 120 (2), e2214829120 (2023).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"25973_CR35","doi-asserted-by":"publisher","first-page":"e925289","DOI":"10.12659\/MSM.925289","volume":"26","author":"Y Zou","year":"2020","unstructured":"Zou, Y. et al. CDK1, CCNB1, and CCNB2 are prognostic biomarkers and correlated with immune infiltration in hepatocellular carcinoma [J]. Med. Sci. Monit. 26, e925289 (2020).","journal-title":"Med. Sci. Monit."},{"key":"25973_CR36","doi-asserted-by":"publisher","unstructured":"Fang, L. et al. Bioinformatics analysis highlight differentially expressed CCNB1 and PLK1 genes as potential Anti-Breast cancer drug targets and prognostic markers [J]. Genes (Basel), 13(4).  https:\/\/doi.org\/10.3390\/genes13040654 (2022).","DOI":"10.3390\/genes13040654"},{"issue":"16","key":"25973_CR37","doi-asserted-by":"publisher","first-page":"6780","DOI":"10.18632\/aging.204253","volume":"14","author":"H Fu","year":"2022","unstructured":"Fu, H. et al. High expression of CCNB1 driven by NcRNAs is associated with a poor prognosis and tumor immune infiltration in breast cancer [J]. Aging (Albany NY). 14 (16), 6780\u20136795 (2022).","journal-title":"Aging (Albany NY)"},{"key":"25973_CR38","doi-asserted-by":"publisher","first-page":"1106175","DOI":"10.3389\/fendo.2022.1106175","volume":"13","author":"X Chen","year":"2022","unstructured":"Chen, X. et al. CCNB1 and AURKA are critical genes for prostate cancer progression and castration-resistant prostate cancer resistant to vinblastine [J]. Front. Endocrinol. (Lausanne). 13, 1106175 (2022).","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"18","key":"25973_CR39","doi-asserted-by":"publisher","first-page":"7473","DOI":"10.18632\/aging.102254","volume":"11","author":"EB Chen","year":"2019","unstructured":"Chen, E. B. et al. HnRNPR-CCNB1\/CENPF axis contributes to gastric cancer proliferation and metastasis [J]. Aging (Albany NY). 11 (18), 7473\u20137491 (2019).","journal-title":"Aging (Albany NY)"},{"issue":"6","key":"25973_CR40","doi-asserted-by":"publisher","first-page":"e14567","DOI":"10.1111\/cbdd.14567","volume":"103","author":"L Hao","year":"2024","unstructured":"Hao, L. et al. Study on the mechanism of Quercetin in Sini Decoction plus ginseng soup to inhibit liver cancer and HBV virus replication through CDK1 [J]. Chem. Biol. Drug Des. 103 (6), e14567 (2024).","journal-title":"Chem. Biol. Drug Des."},{"key":"25973_CR41","doi-asserted-by":"publisher","first-page":"1000847","DOI":"10.3389\/fmolb.2022.1000847","volume":"9","author":"Q Gao","year":"2022","unstructured":"Gao, Q. et al. Identification of the hub and prognostic genes in liver hepatocellular carcinoma via bioinformatics analysis [J]. Front. Mol. Biosci. 9, 1000847 (2022).","journal-title":"Front. Mol. Biosci."},{"issue":"5","key":"25973_CR42","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1177\/15353702211049149","volume":"247","author":"MH Rong","year":"2022","unstructured":"Rong, M. H. et al. CCNB1 promotes the development of hepatocellular carcinoma by mediating DNA replication in the cell cycle [J]. Exp. Biol. Med. (Maywood). 247 (5), 395\u2013408 (2022).","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"25973_CR43","doi-asserted-by":"publisher","unstructured":"Alwadi, D. et al. Endocrine disrupting chemicals influence hub genes associated with aggressive prostate cancer [J]. Int. J. Mol. Sci., 24(4).  https:\/\/doi.org\/10.3390\/ijms24043191 (2023).","DOI":"10.3390\/ijms24043191"},{"issue":"2","key":"25973_CR44","doi-asserted-by":"publisher","first-page":"2780","DOI":"10.1021\/acsomega.2c07480","volume":"8","author":"Y Wu","year":"2023","unstructured":"Wu, Y. et al. Z-Guggulsterone induces cell cycle arrest and apoptosis by targeting the p53\/CCNB1\/PLK1 pathway in Triple-Negative breast cancer [J]. ACS Omega. 8 (2), 2780\u20132792 (2023).","journal-title":"ACS Omega"},{"issue":"3","key":"25973_CR45","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s10549-022-06801-2","volume":"198","author":"AI Aljohani","year":"2023","unstructured":"Aljohani, A. I. et al. The clinical significance of Cyclin B1 (CCNB1) in invasive breast cancer with emphasis on its contribution to lymphovascular invasion development [J]. Breast Cancer Res. Treat. 198 (3), 423\u2013435 (2023).","journal-title":"Breast Cancer Res. Treat."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-25973-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-25973-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-25973-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T12:51:38Z","timestamp":1764161498000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-25973-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,26]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["25973"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-25973-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,26]]},"assertion":[{"value":"30 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All procedures involving human tissues were conducted in accordance with the Declaration of Helsinki and approved by the Ethics Committee of Fudan University Shanghai Cancer Center (Approval Number: 2212267-7). Patient-derived organoids (PDOs) were established from freshly resected pancreatic cancer tissues with informed consent. All animal studies were performed in compliance with the Guide for the Care and Use of Laboratory Animals, in accordance with the ARRIVE guidelines and approved by the Institutional Animal Care and Use Committee (IACUC) of Fudan University Shanghai Cancer Center (Permission Number: FUSCC-IACUC-2023241).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics declaration"}}],"article-number":"42044"}}